Literature DB >> 8032622

Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage.

C E Austin1, J C Foreman, G K Scadding.   

Abstract

In subjects with allergic rhinitis to house-dust mite (HDM), antigen challenge produced a significant increase in nasal blockage but had no effect on nasal vascular permeability. The B2 kinin receptor antagonist, [D-Arg0,Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (Hoe 140), 200 micrograms administered by intranasal aerosol 2 min prior to challenge with HDM, 500 u significantly reduced nasal blockage induced by the antigen challenge. The data are compatible with a role for B2 kinin receptors in the nasal response to challenge with antigen which is responsible for nasal blockage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032622      PMCID: PMC1910147          DOI: 10.1111/j.1476-5381.1994.tb14835.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.

Authors:  J Spragg; R J Vavrek; J M Stewart
Journal:  Peptides       Date:  1988 Jan-Feb       Impact factor: 3.750

2.  Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat.

Authors:  D Proud; C J Reynolds; S Lacapra; A Kagey-Sobotka; L M Lichtenstein; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-03

Review 3.  Measurement of feelings using visual analogue scales.

Authors:  R C Aitken
Journal:  Proc R Soc Med       Date:  1969-10

4.  Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.

Authors:  C E Austin; J C Foreman
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

5.  Mediator release after nasal airway challenge with allergen.

Authors:  R M Naclerio; H L Meier; A Kagey-Sobotka; N F Adkinson; D A Meyers; P S Norman; L M Lichtenstein
Journal:  Am Rev Respir Dis       Date:  1983-10

6.  Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.

Authors:  C Svensson; M Andersson; C G Persson; P Venge; U Alkner; U Pipkorn
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

7.  Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers.

Authors:  K Rajakulasingam; R Polosa; S T Holgate; P H Howarth
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

8.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.

Authors:  F J Hock; K Wirth; U Albus; W Linz; H J Gerhards; G Wiemer; S Henke; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

  8 in total
  8 in total

Review 1.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.

Authors:  J W Dear; K Wirth; G K Scadding; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.

Authors:  C Bandeira-Melo; A S Calheiros; P M Silva; R S Cordeiro; M M Teixeira; M A Martins
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 4.  A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.

Authors:  Devasahayam Arokiar Balaya Rex; Neelanchal Vaid; K Deepak; Shobha Dagamajalu; T S Keshava Prasad
Journal:  Mol Biol Rep       Date:  2022-05-21       Impact factor: 2.742

5.  Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.

Authors:  J W Dear; S Ghali; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 6.  The kinin system in rhinitis and asthma.

Authors:  D Proud
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

7.  Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa.

Authors:  Hideaki Shirasaki; Etsuko Kanaizumi; Tetsuo Himi
Journal:  Mediators Inflamm       Date:  2009-04-23       Impact factor: 4.711

8.  Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid.

Authors:  Radoslaw Gawlik; Alicja Grzanka; Barbara Jawor; Eugeniusz Czecior
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.